Apyx Medical Corp Receivables Turnover Ratio (APYX), from the second quarter 2026 to the second quarter 2025 current and historic results, rankings and more - CSIMarket
CSIMarket
 


Apyx Medical Corp  (NASDAQ: APYX)
 

Apyx Medical Accounts Receivables Turnover Ratio from the second quarter 2026 to the second quarter 2025

Quarterly Results, Trends, Rankings, Statistics


Apyx Medical Corp's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the second quarter 2026 to a ratio of 4.14, this is below the company average, and notable indication of worsening business environment. Average receivable collection period, for the Apyx Medical in Jun 30 2026 quarter, has decreased to 88 days, compared to 89 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 433 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 2990, from overall ranking in the first quarter 2026 at 3543.

What is Receivable Turnover Ratio?
What is Apyx Medical Corp Selling?


What is Receivable Turnover Ratio?





APYX Receivables Turnover Ratio (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Receivable Change 21.03 % 9.53 % 8.37 % -0.31 % -11.5 %
Y / Y Revenue Change 25.27 % 37.62 % 33.65 % 12.26 % -3.57 %
Receivable Turnover Ratio (TTM) 4.14 4.11 3.95 3.66 3.55
APYX's Total Ranking # 2990 # 3543 # 3180 # 3218 # 3271
Accounts Receivable average collection period days 88 89 92 100 103
Seq. Receivable Change 6.73 % -23.97 % 29.1 % 15.53 % -3.41 %
Seq. Revenue Change 16.43 % -40.37 % 62.63 % 10.95 % 27.91 %


Receivable Turnover Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 158
Healthcare Sector # 434
Overall Market # 2990

Receivable Turnover Ratio Statistics
High Average Low
14.8 6.56 1.89
(Jun 30 2015)   (Dec 31 2020)






Financial Statements
Apyx Medical's Accounts Receivable $ 14 Millions Visit APYX's Balance sheet
Apyx Medical's Sales TTM $ 58 Millions Visit APYX's Income Statement
Sources of APYX's Revenues Visit APYX's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
APYX's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
APYX's Growth Rates APYX's Roa APYX's Inventory Turnover Ratio APYX's Dividend Comparisons
APYX's Profitability Ratios APYX's Roi APYX's Asset Turnover Ratio APYX's Dividend Growth
APYX's Valuation Ratios APYX's Roe APYX's Financial Strength Ratios APYX's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Receivable at quarter ending Jun 30 2026
Marpai Inc  11.71 $ 16.635  Millions$ 1.420  Millions
Catheter Precision Inc   11.62 $ 1.915  Millions$ 0.165  Millions
Icu Medical Inc  11.42 $ 2,159.998  Millions$ 189.166  Millions
National Healthcare Corp  11.40 $ 1,559.020  Millions$ 136.723  Millions
Nrc Health  11.35 $ 139.996  Millions$ 12.337  Millions
Picard Medical Inc   11.34 $ 5.983  Millions$ 0.528  Millions
Veracyte Inc   11.07 $ 544.735  Millions$ 49.194  Millions
International Stem Cell Corporation  10.91 $ 9.514  Millions$ 0.872  Millions
Premier Air Charter Holdings Inc   10.66 $ 31.562  Millions$ 2.961  Millions
C4 Therapeutics Inc   10.65 $ 35.039  Millions$ 3.290  Millions
Lifeloc Technologies Inc   10.48 $ 9.269  Millions$ 0.884  Millions
Irhythm Holdings Inc   10.32 $ 825.702  Millions$ 80.007  Millions
Immucell Corporation  10.29 $ 29.777  Millions$ 2.893  Millions
Addus Homecare Corp  10.23 $ 1,475.610  Millions$ 144.195  Millions
Dariohealth Corp   10.23 $ 21.196  Millions$ 2.072  Millions
Biodesix Inc   10.21 $ 102.939  Millions$ 10.081  Millions
Radnet Inc   10.11 $ 2,268.932  Millions$ 224.447  Millions
Utah Medical Products Inc  9.88 $ 35.679  Millions$ 3.612  Millions
Lensar Inc   9.75 $ 60.264  Millions$ 6.184  Millions
Biolife Solutions Inc   9.67 $ 102.718  Millions$ 10.626  Millions
Encompass Health Corporation  9.57 $ 6,206.100  Millions$ 648.325  Millions
The Oncology Institute Inc   9.57 $ 587.244  Millions$ 61.364  Millions
Alumis inc   9.44 $ 7.398  Millions$ 0.784  Millions
Enanta Pharmaceuticals Inc  9.29 $ 65.258  Millions$ 7.027  Millions
Neuronetics Inc   9.24 $ 154.594  Millions$ 16.732  Millions
Harmony Biosciences Holdings inc   9.22 $ 960.191  Millions$ 104.164  Millions
Pavmed Inc   9.16 $ 0.126  Millions$ 0.014  Millions
Ardent Health Inc   9.16 $ 6,405.940  Millions$ 699.363  Millions
The Pennant Group Inc   9.15 $ 1,101.710  Millions$ 120.457  Millions
Lexicon Pharmaceuticals Inc   9.14 $ 41.469  Millions$ 4.535  Millions

Date modified: 2026-09-08T16:32:55+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.